XML 102 R87.htm IDEA: XBRL DOCUMENT v3.22.4
Income taxes - Narrative (Detail)
12 Months Ended
Dec. 31, 2022
USD ($)
Components Of Income Tax Expense Benefit [Line Items]  
Approximately valuation allowance increased $ 69,700,000
Income tax examination, penalties and interest accrued 0
Capitalized research and development expense $ 232,100,000
Research Tax Credit Carryforward  
Components Of Income Tax Expense Benefit [Line Items]  
Limitations on use of net operating losses and tax credit carryforwards, percentage 50.00%
Limitations on use of net operating losses and tax credit carryforwards, period 3 years
U.S.  
Components Of Income Tax Expense Benefit [Line Items]  
Operating loss carryforwards $ 96,100,000
U.S. | Research Tax Credit Carryforward  
Components Of Income Tax Expense Benefit [Line Items]  
Tax credit carryforward amount 8,100,000
State and Local Jurisdiction  
Components Of Income Tax Expense Benefit [Line Items]  
Operating loss carryforwards 113,500,000
State and Local Jurisdiction | Research Tax Credit Carryforward  
Components Of Income Tax Expense Benefit [Line Items]  
Tax credit carryforward amount $ 3,300,000